Baccharis articulata is native of América and traditionally used for the treatment of digestive disorders and urinary infections. Cytotoxicity of aqueous extracts of B. articulata was investigated in Vero cells. As the maximal non cytotoxic concentration has been established, this concentration has been used to evaluate antiviral and virucidal activities against Herpes suis virus type 1, member of the same subfamily of Herpes simplex virus. Aqueous extracts of B. articulata exhibited more than 95% of virucidal activity. These findings support their potential application as a disinfectant or antiseptic with low toxicity and provide a valuable knowledge to ethnopharmacology properties of Baccharis articulata.
PalaciosP.S., WilsonE.G., DebenedettiS.L. (1999) HPLC analysis cafeilquínicos acid present in three species of Baccharis. Dominguezia, 15, 39; (b) De Oliveira SQ, Dal-Pizzol F, Gosmann G, Guillaume D, Moreira JC, Schenkel E. (2003) Antioxidant activity of Baccharis articulata extracts: isolation of new compound with antioxidant activity. Free Radical Research, 37, 555-559; (c) Vivot Lupi EP, Sanchez Brisuela CI, Casik Jeifetz F, Sequin Acosta CJ. (2009) Screening of antifungal activity of extracts of plant species in Entre Ríos. Revista Cubana de Farmacia, 43, 74-84.
2.
KimberlinD.W., WhitleyR.J. (1996) Antiviral resistance: Mechanisms, Clinical Significance and Future Implications. Journal of Antimicrobial Chemotherapy, 37, 403–421
3.
AmbrogiA., GiraudoJ., BussoJ., BiancoO., BagnatE., Segura de AramburuM., RamosB., CeriattiF. (1981) Primer diagnóstico de la enfermedad de Aujeszky en cerdos en la República Argentina. Gaceta Veterinaria. Buenos Aires, Tomo XLIII, 357, 58–64
4.
DulbeccoR. (1962) Production of plaques in monolayer tissue culture by single particles of an animal virus. Proceedings of the National Academy of Sciences, USA, 38, 747–752
